Clinical Trial Detail

NCT ID NCT02979366
Title Phase I Study of S64315 Administred Intravenously in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Institut de Recherches Internationales Servier
Indications

acute myeloid leukemia

myelodysplastic syndrome

Therapies

MIK665

Age Groups: senior adult

No variant requirements are available.